Dilator

FIELD OF THE INVENTION

The present invention relates to an apparatus and a method for sealing a puncture in a tubular tissue structure or the wall of a body cavity. More particularly, the present invention is directed to sealing a puncture site with submucosal tissue or another extracellular matrix-derived tissue capable of remodeling endogenous connective tissue or with a synthetic bioabsorbable material.

BACKGROUND AND SUMMARY

The control of bleeding during and after surgery is important to the success of the procedure. The control of blood loss is of particular concern if the surgical procedure is performed directly upon or involves the patient's arteries and veins. Well over one million surgical procedures are performed annually which involve the insertion and removal of catheters into and from arteries and veins. Accordingly, these types of vasculature procedures represent a significant amount of surgery in which the control of bleeding is of particular concern.

Typically, the insertion of a catheter creates a puncture through the vessel wall and upon removal the catheter leaves a puncture opening through which blood may escape and leak into the surrounding tissues. Therefore, unless the puncture site is closed clinical complications may result leading to increased hospital stays with the associated costs. To address this concern, medical personnel are required to provide constant and continuing care to a patient who has undergone a procedure involving an arterial or venous puncture to insure that post-operative bleeding is controlled.

Surgical bleeding concerns can be exacerbated by the administration of a blood thinning agent, such as heparin, to the patient prior to a catheterization procedure. Since the control of bleeding in anti-coagulated patients is much more difficult to control, stemming blood flow in these patients can be troublesome. A common method of healing the puncture to the vessel is to maintain external pressure over the vessel until the puncture seals by natural clot formation processes. This method of puncture closure typically takes about thirty to ninety minutes, with the length of time usually being greater if the patient is hypertensive or anti-coagulated.

Furthermore, it should be appreciated that utilizing pressure, such as human hand pressure, to control bleeding suffers from several drawbacks regardless of whether the patient is hypertensive or anti-coagulated. In particular, when human hand pressure is utilized, it can be uncomfortable for the patient, can result in excessive restriction or interruption of blood flow, and can use costly professional time on the part of the hospital staff. Other pressure techniques, such as pressure bandages, sandbags, or clamps require the patient to remain motionless for an extended period of time and the patient must be closely monitored to ensure the effectiveness of these techniques.

Other devices have been disclosed which plug or otherwise provide an obstruction in the area of the puncture (see, for example, U.S. Pat. Nos. 4,852,568 and 4,890,612) wherein a collagen plug is disposed in the blood vessel opening. When the plug is exposed to body fluids, it swells to block the wound in the vessel wall. A potential problem with plugs introduced into the vessel is that particles may break off and float downstream to a point where they may lodge in a smaller vessel, causing an infarct to occur. Another potential problem with collagen plugs is that there is the potential for the inadvertent insertion of the collagen plug into the lumen of the blood vessel which is hazardous to the patient. Collagen plugs also can act as a site for platelet aggregation, and, therefore, can cause intraluminal deposition of occlusive material creating the possibility of a thrombosis at the puncture sight. Other plug-like devices are disclosed, for example, in U.S. Pat. Nos. 5,342,393, 5,370,660 and 5,411,520.

Accordingly, there is a need for surgical techniques suitable for sealing punctures in a tubular tissue structure or in the punctured wall of a body cavity, such as a heart chamber, or a body cavity of another organ. Such techniques require rapid, safe, and effective sealing of the puncture. It would also be advantageous to close the puncture without disposing any occlusive material into the vessel or body cavity, and without introducing infectious organisms into the patient's circulatory system.

The present invention is directed to an apparatus and method for sealing punctured tubular tissue structures, including arteries and veins, such as punctures which occur during diagnostic and interventional vascular and peripheral catheterizations, or for sealing a puncture in the wall of a body cavity. More specifically, the apparatus and method of the present invention employ submucosal tissue or another extracellular matrix-derived tissue or a synthetic bioabsorbable material to seal punctures in tubular tissue structures, such as blood vessels, or in the wall of a body cavity. The submucosal tissue or other extracellular matrix-derived tissue is capable of inducing tissue remodeling at the site of implantation by supporting the growth of connective tissue in vivo, and has the added advantages of being tear-resistant so that occlusive material is not introduced into the patient's circulatory system. Also, submucosal tissue or another extracellular matrix-derived tissue has the advantage of being resistant to infection, thereby reducing the chances that the procedure will result in systemic infection of the patient.

In one embodiment, a device for sealing a puncture site in the wall of a body is provided. The device comprising an elongated element having a tissue wall contact exterior portion; a bioabsorbable member releasably attached to the tissue wall contact exterior portion of the elongated element; and a removable cover disposed over at least a portion of the elongated element and a portion of the bioabsorbable member.

In another embodiment a method of sealing a puncture site in the wall of a body is provided. The method comprises the steps of providing an elongated element having a tissue wall contact exterior portion and an elongated element lumen therein; providing a bioabsorbable member releasably attached to the tissue wall contact exterior portion of the elongated element; and providing a removable cover having a portion disposed within the elongated element lumen and a portion extending over at least a portion of the bioabsorbable member to produce a sealing device.

In an alternate embodiment a device for sealing a puncture site in the wall of a body is provided. The device comprising an elongated element having a tissue wall contact exterior portion; a bioabsorbable member releasably disposed on the tissue wall contact exterior portion of the elongated element; and a removable cover disposed over at least a portion of the elongated element and a distal end of the bioabsorbable member.

In another embodiment a method of sealing a puncture site in the wall of a body cavity is provided. The method comprises the step of inserting an intact extracellular matrix-derived tissue of a warm-blooded vertebrate into the puncture site.

BRIEF DESCRIPTION OF THE DRAWINGS

FIGS. 1 A-I illustrate introducer elements for use in sealing access to a tubular tissue structure or a body cavity.

FIGS. 2 A-I illustrate various tether configurations on introducer elements for use in sealing access to a tubular tissue structure or a body cavity.

FIGS. 3 A-C illustrate views of various embodiments of a tubular spacer element.

FIGS. 4 A-C illustrate views of various embodiments of a tubular spacer element.

FIG. 5 illustrates a portion of an introducer element having a tubular spacer element.

FIGS. 6 A-C illustrate an embodiment of a retaining mechanism.

FIGS. 7, 7A and 7B illustrate an embodiment of a retaining mechanism.

FIGS. 8 A-C illustrate an embodiment of a retaining mechanism and a mechanism for holding the sheet 18 in place on the introducer element.

FIGS. 9 A and E, B and F, C and G, and D and H illustrate perspective views of the tops and bottoms, respectively, of various tissue graft embodiments. FIG. 9 I illustrates a perspective view of the top of a graft embodiment.

FIGS. 10 A-G illustrate an embodiment of a method of sealing access to a tubular tissue structure or a body cavity.

FIGS. 11 A-F illustrate an embodiment of a method of sealing access to a tubular tissue structure or a body cavity.

FIG. 12 illustrates an embodiment of a mechanism for holding the sheet 18 in place on the introducer element.

FIG. 13 illustrates an embodiment of a method of sealing access to a tubular tissue structure or a body cavity.

FIG. 14 illustrates embodiments of stitch patterns 138, 140, 142, and 144 for the sheet 18.

FIG. 15 illustrates an embodiment of a method of sealing access to a tubular tissue structure or a body cavity.

FIG. 16 illustrates an embodiment of a device for sealing access to a tubular tissue structure or a body cavity.

FIGS. 17A-D illustrate an embodiment of a device for sealing access to a tubular tissue structure or a body cavity including a balloon sheath.

FIGS. 18A-B illustrate an embodiment of a device for sealing access to a tubular tissue structure or a body cavity including a capsule

DETAILED DESCRIPTION

The present invention is related to an apparatus and a method for sealing a puncture in a tubular tissue structure, such as a blood vessel, or in the wall of a body cavity, with submucosal tissue, another extracellular matrix-derived tissue, or a synthetic bioabsorbable material capable of supporting the growth of endogenous connective tissue in vivo resulting in remodeling of endogenous connective tissue at the puncture site and in formation of a static seal. The apparatus and method of the present invention can be used to seal a puncture in a tubular tissue structure, such as a blood vessel, or in the wall of a body cavity, that has been created intentionally or unintentionally during a surgical procedure or nonsurgically (e.g., during an accident). Punctures made intentionally include vascular punctures made in various types of vascular, endoscopic, or orthopedic surgical procedures, or punctures made in any other type of surgical procedure, in coronary and in peripheral arteries and veins or in the wall of a body cavity. Such procedures include angiographic examination, angioplasty, laser angioplasty, valvuloplasty, atherectomy, stent deployment, rotablator treatment, aortic prosthesis implantation, intraortic balloon pump treatment, pacemaker implantation, any intracardiac procedure, electrophysiological procedures, interventional radiology, and various other diagnostic, prophylactic, and therapeutic procedures such as dialysis and procedures relating to percutaneous extracorporeal circulation.

Referring now to the drawings, FIG. 1 illustrates an introducer 10 adapted for catheterization, exemplary of the type of introducer element that may be used in accordance with the present invention. Although an introducer 10 adapted for use in catheterization procedures is illustrated in FIG. 1, it is understood that the present invention is applicable to any type of introducer element used to provide access to the lumen of a tubular tissue structure, such as a blood vessel, or to a body cavity. For example, the present invention is applicable to an introducer element such as a needle, a cannula, a guide wire, an introducer element adapted for dialysis, a trocar, or any other introducer element used to access the lumen of a tubular tissue structure or a body cavity.

An introducer 10 as depicted in FIG. 1 can be used when performing catheterization procedures in coronary and peripheral arteries and veins. Typically, a catheter is introduced into the vascular system by first penetrating the skin, underlying muscle tissue, and the blood vessel with a needle, and a guide wire is inserted through the lumen of the needle and enters the blood vessel. Subsequently, the needle is stripped off the guide wire and an introducer 10 is fed over the guide wire and pushed through the skin and through the vessel wall to enter the vessel. The guide wire can then be removed and a catheter is fed through the lumen of the introducer 10 and advanced through the vascular system until the working end of the catheter is positioned at a predetermined location. Alternatively, the guide wire may be left in place throughout the procedure and the introducer 10 removed before the guide wire is removed. At the end of the catheterization procedure, the catheter is withdrawn. The introducer 10 is also removed and the opening through which, for example, the introducer 10 is inserted must be sealed as quickly as possible once the procedure is completed. Although a typical catheterization procedure utilizing an introducer 10 is described, the described procedure is non-limiting. Furthermore any embodiment of the introducer 10 described below is applicable to any other introducer element for use in accessing the lumen of a tubular tissue structure or a body cavity.

The present invention may be employed, for example, to rapidly seal a puncture site in a blood vessel upon completion of a catheterization procedure. The introducer 10 illustrated in FIG. 1 A-I is an exemplary embodiment and has a user distal end 12 for insertion into a blood vessel and a user proximal end 14. A standard introducer comprises a dilator 17 and a sheath 16 which extends axially over the dilator 17, a sheath cap 20 disposed axially over a portion of the sheath 16 and a valve cap 22 connected to the sheath cap 20 and to a side port tube 24. A standard introducer may also comprise a three-way valve 26 connected to an end of the side port tube 24, and a syringe connector 28, adapted for the attachment of a syringe to the introducer 10 and connected to the valve cap 22. Although not part of a standard introducer, the introducer 10 depicted in FIG. 1 further comprises a positioning tube 44 which extends axially over a portion of the sheath 16, and a sheet 18 of submucosal tissue or another extracellular matrix-derived tissue or a synthetic bioabsorbable material extending axially over a portion of the positioning tube 44.

In the embodiment of the invention depicted in FIG. 1 (see FIG. 1 B), a sheet 18 of submucosal tissue or another extracellular matrix-derived tissue or a synthetic bioabsorbable material extends axially over a portion of the positioning tube 44 (described in more detail below), and the positioning tube 44 extends axially over the sheath 16. FIG. 1 E-G depicts the sheath 16, the dilator 17, the positioning tube 44, and the sheet 18 in a disassembled cross-sectional form, and assembled to construct an introducer 10. The sheet 18 has a user distal end 30 which is inserted into a tubular tissue structure, such as a blood vessel, and a user proximal end 32 which remains outside of the punctured vessel wall. The proximal end 32 of the sheet 18 may extend axially over a portion of the introducer 10 as depicted in FIG. 1 or may extend to and be held in place by the sheath cap 20.

In embodiments where the user proximal end 32 of the sheet 18 does not extend to the sheath cap 20, the user proximal end 32 of the sheet 18 may be held in place, for example, by a string attached to the user proximal end 32 of the sheet 18 and the sheath cap 20 or the valve cap 22. As a result, the sheet 18 is prevented from being pushed down the introducer 10 when the user inserts the introducer 10 through, for example, a vessel wall with his hand in contact with the sheet 18. The string may be cut to permit the user proximal end 32 of the sheet 18 to be gathered externally to seal the puncture site as described below. In other embodiments, the user proximal end 32 of the sheet 18 or other parts of the sheet 18 may be held in place by metal or plastic clamps, O-rings, or the like, which may be removed from the end of the sheet 18 when it is necessary to gather the sheet 18 externally to seal the puncture site. Alternatively, as shown in FIG. 1, the sheet 18 may extend axially over only a portion of the introducer 10 so that the proximal end 32 of the sheet 18 is distal to the points at which the hand of the user contacts the introducer 10 and does not come in contact with the hand of the user when the introducer 10 is being inserted through the vessel wall. The sheet 18 can be of any length (e.g., in the form of a disk), as long as the sheet 18 is of sufficient length to plug the puncture site in the vessel wall or in the wall of a body cavity.

As also depicted in FIG. 1 (see FIG. 1 B), in one embodiment the user distal end 30 of the sheet 18 is tapered from the user distal end 30 towards the user proximal end 32 to prevent the sheet 18 from rolling up the introducer 10 upon insertion into the blood vessel when the sheet 18 is positioned, as shown in FIG. 10 A during insertion into the blood vessel. Although, a sheet 18 tapered at the user distal end 30 is depicted in FIG. 1, any configuration of the user distal end 30 of the sheet 18 can be used which prevents the sheet 18 from rolling up the introducer 10 upon insertion into the blood vessel.

As shown in FIGS. 1 and 2, in one illustrative embodiment the sheet 18 has at least one or more tethers 35, 37 attached at or near to the distal end 30 of the sheet 18 and at least one tether 39 attached at or near to the proximal end 32 of the sheet 18. For example, as depicted in FIG. 2 G one or more pull-up tethers 37 may be attached at or near to the distal end 30 of the sheet 18, and one or more pull-down tethers 39 may be attached at or near to the proximal end 32 of the sheet 18. As also depicted in FIG. 2, one or more retaining tethers 35 may be attached at or near to the distal end 30 of the sheet 18. The function of each of the various types of tethers is described below.

The pull-up tether 37 is attached to the sheet 18 at or near the distal end 30 of the sheet 18 and extends axially upwards towards the proximal end 32 of the sheet 18 between the positioning tube 44 and the sheet 18. Thus, the distal end 41 of the pull-up tether is inserted into the blood vessel when the introducer 10 is pushed through the vessel wall and the proximal end 43 of the pull-up tether 37 remains externally exposed. Upon completion of the procedure, such as catheterization, the proximal end 43 of the pull-up tether 37 is pulled to gather the distal end 30 of the sheet 18 in the puncture site or on the inside of the vessel wall (see FIG. 10 C-D).

The pull-down tether 39 is attached at or near the proximal end 32 of the sheet 18 and extends axially downwards between the sheet 18 and the positioning tube 44 towards the distal end 46 of the positioning tube 44. The pull-down tether 39 further extends radially inwards under the positioning tube 44 and then extends axially upwards between the positioning tube 44 and the sheath 16 towards the proximal end 48 of the positioning tube 44. Thus, the attached end 45 and the unattached end 47 of the pull-down tether 39 remain externally exposed when the introducer 10 is inserted into the blood vessel wall. Upon completion of the procedure the unattached end 47 of the pull-down tether is pulled to gather the proximal end 32 of the sheet 18 in the puncture site from the outside of the vessel wall (see FIG. 10 D-E).

In one embodiment, a retaining tether 35 is attached (see FIG. 2 G) to the distal end 30 of the sheet 18. As is described in more detail below with reference to FIG. 5, the distal end 49 of the retaining tether 35 is attached at or near the distal end 30 of the sheet 18. The retaining tether 35 extends axially upwards towards the proximal end 48 of the positioning tube 44 between the sheath 16 and the positioning tube 44. The distal end 49 of the retaining tether 35 is inserted into the blood vessel when the introducer 10 is pushed through the vessel wall. The proximal end 51 of the retaining tether 35 remains externally exposed. The function of the retaining tether is described below with reference to FIG. 5.

In various illustrative embodiments, the sheet 18 has one or more retaining tethers 35, one or more pull-up tethers 37, and one or more pull-down tethers 39. However, the sheet 18 may have any combination of pull-up tethers 37, pull-down tethers 39, and retaining tethers 35, or may lack one or more types of tethers. For example, the sheet 18 may lack a retaining tether 35 or a pull-down tether 39. In this embodiment where only a pull-up tether 37 is attached to the sheet 18, the pull-up tether 37 is used to gather the sheet 18 in the puncture site and against the inside of the vessel wall. Exemplary combinations of tethers are shown in FIG. 2 A-J, but these combinations are not limiting.

Tethers with different functions (i.e., the retaining tether 35, the pull-up tether 37, and the pull-down tether 39) may have different indicia disposed thereon, such as different colors, so that the user can easily identify the tether with the desired function. Alternatively, tethers with different functions may have different caps attached to the externally exposed ends as shown in FIGS. 1-2 and 9-10 so that the tether with the desired function can be easily identified. In one illustrative embodiment, the tethers are made of resorbable thread and the tethers can be attached to the sheet 18 by any suitable means. For example, the tethers can be tied to the sheet 18 or hooked to the sheet 18 by using hooks, barbs, etc. (e.g., for tethers with attachment points that remain externally exposed when the introducer 10 is inserted into the vessel wall).

In one embodiment of the invention the positioning tube 44 (see FIGS. 1-4 and 10) extends axially over a portion of the sheath 16 and is positioned beneath the sheet 18. In another embodiment, the positioning tube 44 is disposed between a tubular spacer element 50, described below, and the sheet 18. The positioning tube 44 is used to insert the sheet 18 into the tubular tissue structure to a predetermined position relative to the sheet 18 (see FIG. 10 A-E). The positioning tube 44 has a user distal end 46, a user proximal end 48, and a tapered ledge 42 (see FIG. 1 I). As the user is inserting the introducer 10 with the sheet 18 through the wall of the tubular tissue structure the user feels resistance when the tapered ledge 42 of the positioning tube 44 reaches the outside of the wall of the tubular tissue structure. Accordingly, the resistance to insertion of the introducer 10 with the sheet 18 into the tubular tissue structure indicates to the user that the sheet 18 has been inserted to the desired, predetermined position relative to the sheet 18. Thus, the tapered ledge 42 of the positioning tube 44 functions as a tactile stop. The positioning tube 44 is exemplary of a mechanism that can be used to insert the sheet 18 into the tubular tissue structure or a body cavity to a predetermined position, but any other mechanism can be used such as, for example, a positioning knot in the sheet 18 itself. In another embodiment, a second layer of bioabsorbable material (e.g., an extracellular matrix-derived tissue) can be attached to the outside of the sheet 18 to form a sleeve cuff 122 to function as a tactile stop (see FIG. 11 A), or more than one layer of bioabsorbable material can be used, for example. Accordingly, for any of the illustrative embodiments described herein, any type of tactile stop can be used and a positioning tube is not required.

In one embodiment of the invention a tubular spacer element 50 (see FIGS. 3-5) is provided for positioning on an introducer element, such as the introducer 10 adapted for catheterization depicted in FIG. 1. The tubular spacer element 50 is used to contain one or more of the retaining tethers 35 attached to the distal end 30 of the sheet 18. In this embodiment, the tubular spacer element 50 is disposed on the sheath 16 as depicted in FIG. 5. The positioning tube 44 is disposed on the tubular spacer element 50 and the sheet 18 is disposed on the positioning tube 44.

As shown in FIG. 5, the tubular spacer element 50 has an outer surface 52, an inner surface 54, a user distal end 56, a user proximal end 58, and at least one ridge 60 extending from the inner surface 54 of the spacer element 50. The distal end 56 of the spacer element 50 is inserted into the blood vessel and the proximal end 58 remains externally exposed. The ridge 60 prevents at least a portion of the inner surface 54 of the spacer element 50 from contacting the sheath 16 to provide at least one lumen 62 between the spacer element 50 and the sheath 16 for containing one or more tethers 35 attached to the distal end 30 (see FIG. 5) of the sheet 18. In another embodiment the tubular spacer element 50 has multiple ridges 60 providing multiple lumens 62 to contain one or more tethers 35. A cross-sectional view of one embodiment of the tubular spacer element 50 with a single ridge 60 is shown in FIG. 3 A-B and a cross-sectional view of the another embodiment with multiple ridges is shown in FIG. 4 A-B.

The tether 35 is inserted into the lumen 62 of the spacer element 50 at the distal end 56 of the spacer element 50 (see FIG. 5) between the tubular spacer element 50 and the sheath 16 and traverses the lumen 62 to the proximal end 58 of the spacer element 50. The proximal end 58 of the spacer element 50 is exposed externally when the introducer 10 is inserted into the tubular tissue structure. Thus, in one embodiment, the user can grasp the externally exposed portion of the tether 35 attached to the distal end 30 of the sheet 18 during insertion of the introducer 10 (i.e., the introducer having the spacer element 50 and the sheet 18) into a tubular tissue structure. As a result, the sheet 18 is prevented from rolling up the introducer 10 upon insertion into the blood vessel. In another embodiment the proximal end 51 of the retaining tether may be attached to the introducer 10, such as to the sheath cap 20 or to the valve cap 22, and the retaining tether 35 may be cut when the user desires to pull the sheet 18 into the puncture site using the pull-up tether 37.

The ridge 60 prevents the inner surface 54 of the spacer element 50 from contacting the sheath 16 to provide at least one lumen 62 between the spacer element and the sheath 16 for containing the tether 35. In one embodiment, more than one ridge 60 may be present on the inner surface 54 of the spacer element (see FIG. 4). In such a way, multiple lumens 62 are provided to contain multiple tethers 35 for use in preventing the sheet 18 from rolling up the introducer 10 upon insertion into the blood vessel. In another embodiment of the invention (see FIGS. 3 C and 4 C), the tubular spacer element 50 comprises a tube 66 with a lumen 62 to contain a tether 35 or multiple lumens 62 to contain multiple tethers 35 for preventing the sheet 18 from rolling up the introducer 10 upon insertion into the blood vessel. The tubular spacer element 50 may also be formed as a positioning tube if a tapered ledge is formed at the distal end 56 of the spacer element 50.

In another embodiment, an apparatus is provided for containing a tether as shown in cross-sectional view in FIG. 3 A-B and FIG. 4 A-B. The apparatus comprises the tubular spacer element 50 for positioning on a sheath 16 wherein the tube has an inner surface 54, an outer surface 52, and at least one ridge 60 on the inner surface 54 to prevent the tubular spacer element 50 from contacting the sheath 16 to provide at least one lumen 62 for containing a tether 35. Embodiments comprising multiple ridges 60 as described above (FIG. 4 A-B) are also contemplated. Alternatively, the ridges might be replaced with grooves in the tubular spacer element 50 to provide lumens 62 for containing tethers 35.

An apparatus comprising a tubular spacer element 50 comprising a tube 66 with one lumen 62 for containing a tether 35 as shown in cross-sectional view in FIG. 3 C is also provided. Alternatively, this embodiment of the invention may comprise multiple lumens 62 to contain multiple tethers 35 as shown in FIG. 4 C.

Any suitable means for preventing the sheet 18 from rolling up the introducer 10 upon insertion into a tubular tissue structure, such as a blood vessel, can be used. Other embodiments for preventing the sheet 18 from rolling up the introducer 10 are depicted in FIGS. 6-8.

As shown in FIG. 6, retaining tethers 80 may be used which are attached to the distal end 30 of the sheet 18 at an attachment point 82 on the distal end 30 of the sheet 18 and extend axially upwards between the sheet 18 and the positioning tube 44 towards the proximal end 14 of the introducer 10. The tethers 80 can be attached to the sheet 18, for example, by tying the tethers 80 to form a knot. Loops 86 are formed from the retaining tethers 80 and the loops 86 originate at the attachment point 82 (see FIG. 6 A). The loops 86 can be fitted over flaps 84 cut in, or otherwise attached to the sheath 16, and the tethers 80 can be pulled towards the user proximal end 14 of the introducer 10 to tighten the loops 86 around the flaps 84 before the introducer 10 is inserted into the tubular tissue structure (see FIG. 6 B).

Accordingly, the user can grasp the proximal end 32 of the sheet 18 and or the tethers 80 upon insertion of the introducer 10 into the tubular tissue structure and prevent the sheet 18 from rolling up the introducer 10. After insertion of the distal end 30 of the sheet 18 through the wall of the tubular tissue structure, the introducer 10 can be pulled towards the user enough to release the loops 86 from the flaps 84 cut in, or attached to, the sheath 16 to permit the distal end 30 of the sheet 18 to be gathered into the puncture site at the necessary time.

Another embodiment for preventing the sheet 18 from rolling up the sheath 16 upon insertion into a tubular tissue structure is shown in FIG. 7. In this embodiment, there is a lumen 104 in, for example, the positioning tube 44. A retaining wire 94 is attached to a cap 87 and the cap 87 is grasped by the user and is used to insert the retaining wire 94 into the lumen 104 through an insertion tube 89. The cap 87 can be screwed onto, or otherwise attached to, the introducer 10 to hold the retaining wire 94 in place in the lumen 104.

As the retaining wire 94 is inserted into the lumen 104, the retaining wire 94 is threaded through a tether 90, in the form of a loop attached to the distal end 30 of the sheet 18 at an attachment point 106. The tether 90 can be attached to the sheet 18, for example, by tying the tether 90 to form a knot. The tether 90 extends radially inwards into the lumen 104 through an access port 92.

Accordingly, the tether 90, anchored by the retaining wire 94, will prevent the sheet 18 from rolling up the introducer 10 upon insertion into the tubular tissue structure. After insertion of the introducer 10 with the sheet 18 through the wall of the tubular tissue structure, the retaining wire 94 can be removed from the lumen 104 by releasing the cap 87 from the introducer 10 and by pulling the retaining wire 94, attached to the cap 87, out of the lumen 104. Thus, the tether 90 is no longer anchored by the retaining wire 94. In another embodiment, the lumen for the retaining wire 94 can be the lumen 124 (see FIGS. 11 A and B) between the dilator 17 and the sheath 16.

In another embodiment a septum 120 (see FIG. 11 A-D) can be attached to the valve cap 22 to provide a hemostatic seal for the retaining wire 94. A replacement cap 91 can be used to close the insertion tube 89 either with or without a septum 120. After completion of the procedure (e.g., a catheterization procedure), the pull-up tether 37 can be used to gather the distal end 30 of the sheet 18 into the puncture site.

FIG. 8 shows an embodiment similar to the embodiment depicted in FIG. 7 except that both the proximal end 32 and the distal end 30 of the sheet 18 are held in place by tethers 90 and 114, in the form of loops, attached to the distal end 30 and the proximal end 32 of the sheet 18, respectively. The tethers 90 and 114 are attached to the sheet 18 at attachment points 116 and 118, respectively. The retaining wire 94 is threaded through the tethers 90 and 114. The tether 114 attached to the proximal end 32 of the sheet 18 is used to hold the proximal end 32 of the sheet 18 in place, particularly when the sheet 18 is in the form of a ribbon with edges that are not joined by, for example, suturing (ribbon forms of the sheet 18 are described below).

In another embodiment, the tether 90 that is in the form of a loop can be made by using a safety tether 128 with a first end 130 and a second end 132 (see FIG. 11 A). The safety tether 128 can be stitched to the sheet 18 axially down the length of the sheet 18 and axially back up the length of the sheet 18 leaving an unstitched portion to make the tether 90 in the form of a loop. The first end 130 and the second end 132 can extend outside of the patient's skin so that the first end 130 and the second end 132 of the safety tether 128 can be pulled to remove the sheet 18 from the puncture site, if necessary, during treatment of the patient.

In the illustrative embodiments where only a pull-up tether 37 and/or a retaining tether 35 are used, a positioning tube 44 is not required. In these embodiments, another type of tactile stop, such as a sleeve cuff 122 as described above, can be used. In another illustrative embodiment, the pull-up tether 37 and pull-down tether 39 can be a single tether 150 (see FIG. 13) and in this embodiment a positioning tube 44 is not required. In this embodiment, the tether can be attached to the proximal end 32 of the sheet 18 and can be stitched axially down the sheet 18 to the distal end 30 of the sheet 18. The tether can then be stitched axially up the sheet 18 to the proximal end 32 of the sheet 18 and can be externally exposed so that the user can grasp the tether. When the user pulls the tether, the sheet 18 gathers on the inside of the vessel wall, in the puncture site, and outside of the vessel wall, or the sheet 18 can be gathered outside the vessel wall in an illustrative embodiment described below. This illustrative tether embodiment can be used in combination with any embodiment of a retaining tether 35 and/or with any embodiment of a safety tether 128. In one illustrative aspect, this tether embodiment can include a knotting mechanism, such as a fisherman's knot, to keep the gathering from being reversed.

As shown in FIG. 9, in an illustrative embodiment, a tissue graft 72 for sealing a puncture site in the wall of a tubular tissue structure, such as a blood vessel, is also provided. In various illustrative embodiments, the tissue graft 72 comprises a sheet 74 of submucosal tissue or another extracellular matrix-derived tissue or a synthetic bioabsorbable material and at least one tether 76 attached at or near at least one end of the sheet 74. The sheet 74 can be in any of the forms described below (i.e., a tube, a disk, a roll, a ribbon, or the like). In alternate embodiments of the invention one tether may be attached near one end of the sheet 74 (see FIG. 9 A), more than one tether may be attached near one end of the sheet 74 (see FIG. 9 B), one tether may be attached near each end of the sheet 74 (see FIG. 9 C), or more than one tether may be attached at both ends of the sheet 74 (see FIG. 9 D). In any of these embodiments, the tethers can form loops. In another embodiment the tether 128 (see FIG. 9 I) can be stitched axially up the length of the sheet 74 and axially down the length of the sheet 74 leaving an unstitched portion to form a loop 90.

Additional illustrative embodiments are provided that can keep the sheet 18 in the vessel puncture site and can aid in hemostasis. In one embodiment, intravascular and extravascular silicone balloons can be used. In another embodiment, intravascular and extravascular anchors can be used. In another illustrative aspect, the anchors can be made of any of the extracellular matrix-derived tissues, submucosa tissue preparations, or synthetic materials described more fully below and the anchors can be bioabsorbable. In another illustrative aspect, the anchors and silicone balloons can be marked with radiopaque material, as described in more detail below, to visualize the location of the sheet 18.

In another illustrative embodiment, the sheath 16 can be coated with a hydrophilic or reduced-friction coating such as a hydrogel, parylene, polyacrylamide, or polyvinyl pyrollidone, or the like. In another illustrative embodiment, the sheath 16 can be laminated with a reduced-friction tubing such as polytetrafluoroethylene (PTFE) or similar tubing with a diameter similar to the diameter of the sheath 16. The hydrophilic coating or laminated tubing can, for example, reduce friction between the sheath 16 and the sheet 18 to prevent the sheet 18 from clinging to the sheath 16 during removal of the sheath 16 from the insertion site.

The submucosal tissue or another extracellular matrix-derived tissue or a synthetic bioabsorbable material can be in the form of a ribbon with unjoined edges (see FIG. 8), a cylindrically-shaped tube with joined edges (see FIG. 6, view B), a disk, a roll wrapped multiple times around the introducer 10, or in any other suitable form.

Exemplary of tissues that can be used to make the sheet 18 are submucosal tissues or any other bioabsorbable materials (e.g., an extracellular matrix-derived tissue of a warm-blooded vertebrate). Submucosal tissue can comprise submucosal tissue selected from the group consisting of intestinal submucosa, stomach submucosa, urinary bladder submucosa, and any other submucosal tissue that is acellular and can be used to remodel endogenous tissue. The submucosal tissue can comprise the tunica submucosa delaminated from both the tunica muscularis and at least the luminal portion of the tunica mucosa of a warm-blooded vertebrate.

It is known that compositions comprising the tunica submucosa delaminated from both the tunica muscularis and at least the luminal portion of the tunica mucosa of the submucosal tissue of warm-blooded vertebrates can be used as tissue graft materials (see, for example, U.S. Pat. Nos. 4,902,508 and 5,281,422 incorporated herein by reference). Such submucosal tissue preparations are characterized by excellent mechanical properties, including high compliance, high tensile strength, a high burst pressure point, and tear-resistance. Thus, the sheets 18 prepared from submucosal tissue are tear-resistant preventing occlusive material from being disposed into the blood vessel.

Other advantages of the submucosal tissue sheets are their resistance to infection, stability, and lack of immunogenicity. Intestinal submucosal tissue, fully described in the aforesaid patents, has high infection resistance. In fact, most of the studies done with intestinal submucosa grafts to date have involved non-sterile grafts, and no infection problems have been encountered. Of course, appropriate sterilization techniques can be used to treat submucosal tissue. Furthermore, this tissue is not recognized by the host's immune system as “foreign” and is not rejected. It has been found that xenogeneic intestinal submucosa is not rejected following implantation as vascular grafts, ligaments, and tendons because of its composition (i.e., submucosal tissue is apparently similar among species). It has also been found that submucosal tissue has a long shelf-life and remains in good condition for at least two months at room temperature without any resultant loss in performance.

Submucosa-derived matrices are collagen based biodegradable matrices comprising highly conserved collagens, glycoproteins, proteoglycans, and glycosaminoglycans in their natural configuration and natural concentration. Such submucosal tissue used as a sheet 18 on an introducer element serves as a matrix for the regrowth of endogenous connective tissues at the puncture site (i.e., biological remodeling, bonding, and hemostasis begin to occur upon insertion of the introducer element with the submucosal tissue sheet 18 into the blood vessel). The submucosal tissue sheet 18 serves as a rapidly vascularized matrix for support and growth of new endogenous connective tissue. Thus, submucosal tissue has been found to be trophic for host tissues with which it is attached or otherwise associated in its implanted environment. In multiple experiments submucosal tissue has been found to be remodeled (resorbed and replaced with autogenous differentiated tissue) to assume the characterizing features of the tissue(s) with which it is associated at the site of implantation or insertion. Additionally, the boundaries between the submucosal tissue and endogenous tissue are not discernible after remodeling. Thus, it is an object of the present invention to provide submucosal tissue for use as a connective tissue substitute, particularly to remodel a puncture site in the wall of a tubular tissue structure or the wall of a body cavity to form a hemostatic seal at the puncture site.

Small intestinal tissue is a preferred source of submucosal tissue for use in this invention. Submucosal tissue can be obtained from various sources, for example, intestinal tissue can be harvested from animals raised for meat production, including, pigs, cattle and sheep or other warm-blooded vertebrates. Small intestinal submucosal tissue is a plentiful by-product of commercial meat production operations and is, thus, a low cost material.

Suitable intestinal submucosal tissue typically comprises the tunica submucosa delaminated from both the tunica muscularis and at least the luminal portion of the tunica mucosa. In one embodiment the intestinal submucosal tissue comprises the tunica submucosa and basilar portions of the tunic a mucosa including the lamina muscularis mucosa and the stratum compactum which layers are known to vary in thickness and in definition dependent on the source vertebrate species.

The preparation of submucosal tissue is described in U.S. Pat. No. 4,902,508, the disclosure of which is expressly incorporated herein by reference. A segment of vertebrate intestine, for example, preferably harvested from porcine, ovine or bovine species, but not excluding other species, is subjected to abrasion using a longitudinal wiping motion to remove the outer layers, comprising smooth muscle tissues, and the innermost layer, i.e., the luminal portion of the tunica mucosa. The submucosal tissue is rinsed with saline and is optionally sterilized.

The submucosal tissue for use as a sheet 18 on an introducer element can be sterilized using conventional sterilization techniques including glutaraldehyde tanning, formaldehyde tanning at acidic pH, propylene oxide or ethylene oxide treatment, gas plasma sterilization, gamma radiation, electron beam, peracetic acid sterilization. Sterilization techniques which do not adversely affect the mechanical strength, structure, and biotropic properties of the submucosal tissue are preferred. For instance, strong gamma radiation may cause loss of strength of the sheets of submucosal tissue. Preferred sterilization techniques include exposing the submucosal tissue sheet to peracetic acid, 1-4 Mrads gamma irradiation (more preferably 1-2.5 Mrads of gamma irradiation), ethylene oxide treatment or gas plasma sterilization. Peracetic acid sterilization is the most preferred sterilization method.

Typically, the submucosal tissue is subjected to two or more sterilization processes. After the submucosal tissue is sterilized, for example, by chemical treatment, the tissue can be wrapped in a plastic or foil wrap, for example, as packaging for the preparation, and sterilized again using electron beam or gamma irradiation sterilization techniques. Alternatively, the introducer element can be assembled with the submucosal tissue sheet 18 on the introducer element and the complete assembly can be packaged and sterilized a second time.

The submucosal tissue can be stored in a hydrated or dehydrated state. Lyophilized or air dried submucosa tissue can be rehydrated and used without significant loss of its biotropic and mechanical properties. The submucosal tissue can be rehydrated before use or, alternatively, is rehydrated during use upon insertion through the skin and into the tubular tissue structure, such as a blood vessel, or a body cavity.

The submucosal tissue can be conditioned, as described in U.S. Pat. No. 5,275,826 (the disclosure of which is expressly incorporated herein by reference) to alter the viscoelastic properties of the submucosal tissue. In accordance with one embodiment submucosa tissue delaminated from the tunica muscularis and luminal portion of the tunica mucosa is conditioned to have a strain of no more than 20%. The submucosal tissue is conditioned by stretching, chemically treating, enzymatically treating or exposing the tissue to other environmental factors. In one embodiment the submucosal tissue is conditioned by stretching in a longitudinal or lateral direction so that the submucosal tissue has a strain of no more than 20%.

When a segment of intestine is first harvested and delaminated as described above, it will be a tubular segment having an intermediate portion and opposite end portions. To form the submucosal tissue sheets 18, sheets of delaminated submucosal tissue can be cut from this tubular segment of intestine to form squares or rectangles of the desired dimensions. The edges of the squares or rectangles can be overlapped and can be joined to form a tubular structure or the edges can be left unjoined. In embodiments where the edges are left unjoined, the sheet 18 can be held in place on the sheath 16, for example, as depicted in FIG. 8 (described above). Thus, the sheet 18 can be in the form of a ribbon with unjoined edges, a tubular structure with overlapped, joined edges, a roll of tissue wrapped around the sheath 16 multiple times, a disk, as described above, or in any other form suitable for use in accordance with the present invention. Such embodiments of the sheet 18 are applicable to submucosal tissue or to other extracellular matrix-derived tissues, or to synthetic bioabsorbable materials and to use with any type of introducer element.

In one embodiment, the edges of the prepared squares or rectangles can be overlapped and joined to form a cylinder-shaped submucosal tissue sheet 18 with the desired diameter. The edges can be joined and a cylinder-shaped sheet formed by applying pressure to the sheet 18 including the overlapped portions by compressing the submucosal tissue between two surfaces. The two surfaces can be formed from a variety of materials and in any cylindrical shape depending on the desired form and specification of the sheet 18. Typically, the two surfaces used for compression are formed as a cylinder and a complementary nonplanar curved plate. Each of these surfaces can optionally be heated or perforated. In preferred embodiments at least one of the two surfaces is water permeable. The term water permeable surface as used herein includes surfaces that are water absorbent, microporous or macroporous. Macroporous materials include perforated plates or meshes made of plastic, metal, ceramics or wood.

The submucosal tissue is compressed in accordance with one embodiment by placing the sheet 18 including the overlapped portions of the sheets of submucosal tissue on a first surface (i.e., inserting a cylinder of the desired dimensions in a cylinder of submucosal tissue) and placing a second surface on top of the exposed submucosal surface. A force is then applied to bias the two surfaces (i.e., the plates) towards one another, compressing the submucosal tissue between the two surfaces. The biasing force can be generated by any number of methods known to those skilled in the art including the application of a weight on the top plate, and the use of a hydraulic press or the application of atmospheric pressure on the two surfaces.

In one preferred embodiment the strips of submucosal tissue are subjected to conditions permitting dehydration of the submucosal tissue concurrent with the compression of the tissue. The term “conditions permitting dehydration of the submucosal tissue” is defined to include any mechanical or environmental condition which promotes or induces the removal of water from the submucosal tissue at least at the points of overlap. To promote dehydration of the compressed submucosal tissue, at least one of the two surfaces compressing the tissue can be water permeable. Dehydration of the tissue can optionally be further enhanced by applying blotting material, heating the tissue or blowing air across the exterior of the two compressing surfaces.

The submucosal tissue is typically compressed for 12-48 hours at room temperature, although heat may also be applied. For example, a warming blanket can be applied to the exterior of the compressing surfaces to raise the temperature of the compressed tissue up to about 50° C. to about 400° C. The overlapped portions are usually compressed for a length of time determined by the degree of dehydration of the tissue. The use of heat increases the rate of dehydration and thus decreases the amount of time the submucosal tissue is required to be compressed. Sufficient dehydration of the tissue is indicated by an increase in impedance of electrical current flowing through the tissue. When impedance has increased by 100-200 ohms, the tissue is sufficiently dehydrated and the pressure can be released.

A vacuum can optionally be applied to submucosal tissue during the compression procedure. The applied vacuum enhances the dehydration of the tissue and may assist the compression of the tissue. Alternatively, the application of a vacuum can provide the sole compressing force for compressing the submucosal tissue including the overlapped edges. For example, the submucosal tissue can be placed between two surfaces, preferably one of which is water permeable. The apparatus is covered with blotting material, to soak up water, and a breather blanket to permit air flow. The apparatus is then placed in a vacuum chamber and a vacuum is applied, generally ranging from 14-70 inches of Hg (7-35 psi). Preferably a vacuum is applied at approximately 51 inches of Hg (25 psi). Optionally a heating blanket can be placed on top of the chamber to heat the submucosal tissue during the compression of the tissue. Chambers suitable for use in this embodiment are known to those skilled in the art and include any device that is equipped with a vacuum port. The resulting drop in atmospheric pressure coacts with the two surfaces to compress the submucosal tissue and simultaneously dehydrate the submucosal tissue. The compressed submucosal tissue can be removed from the two surfaces as a cylinder. The construct can be further manipulated (i.e., tethers can be attached) as described above.

In alternate embodiments, the overlapped portions of the submucosal tissue sheet or extracellular matrix-derived material or synthetic material can be attached to each other by suturing with resorbable thread or by any other method of bonding the overlapped edges known to a person skilled in the art. Such methods of attaching the overlapped edges of the sheet to each other can be used with or without compression to form, for example, a cylindrically-shaped tube, a roll, or a disk. The sheet 18 can also be formed from multiple layers of submucosal tissue attached to each other by compression as described above. The diameter of the sheet 18 can vary depending on the desired specifications of the sheet. For example, the diameter of the sheet can be from about 3 to about 12 french when a sheet 18 is used on an introducer element adapted for catheterization but any diameter can be used depending on the diameter of the introducer element.

Methods of preparing other extracellular matrix-derived tissues are known to those skilled in the art and may be similar to those described above for submucosal tissue. For example, see WO 01/45765 and U.S. Pat. No. 5,163,955, incorporated herein by reference. Extracellular matrix-derived tissues include such tissue preparations as liver basement membrane, pericardial tissue preparations, sheet-like collagen preparations, denatured collagen, gelfoam, and the like.

In another illustrative embodiment, synthetic materials can be used to form the sheet 18. Synthetic materials that can be used include biodegradable polymers such as polylactic acid (PLA), polyglycolic acid (PGA), poly(lactic acid-glycolic acid) copolymer (PLGA), poly-ε-caprolactone (PCL), poly(glycolic acid-caprolactone) copolymer (PGCL), polyanhydride, polyorthoester, and copolymers and mixtures thereof. Additional suitable materials include: collagen, gelatin, thrombin, synthetic protein based materials including alginate polysaccharides, polysaccaride films, lipids, sorbitol, glycerol, polypeptides, and any pro-coagulant material. The biodegradable polymers and other materials can be, for example, in the form of a film, a sheet, a tube, a disk, a roll, or a ribbon. Illustratively, the materials can be woven and can be expandable or nonexpandable. The materials should be bioabsorbable, nonimmunogenic, and tear-resistant. Mixtures of the submucosal tissues, extracellular matrix-derived tissues, synthetic materials, and other materials can also be used.

In yet other illustrative embodiments, any of the extracellular matrix-derived tissues, the submucosal tissue preparations, or the synthetic materials described above, can be impregnated with biological response modifiers such as glycoproteins, glycosaminoglycans, chondroitin compounds, laminin, poly-n-acetyl glucosamine, chitosan, chondroitin, zeolite, potato starch, tranexamic acid, aminocaproic acid, desmopressin acetate, crushed collagen, gelfoam, clotting agents or clot protectors, such as thrombin, fibrin, fibrinogen, anti-fibrinolytics, factors VII, VIII, XIII, and the like, procoagulants, barriers, tissue factor, or blood factors, growth factors, and the like, or combinations of these biological response modifiers. These biological response modifiers can be placed at any effective location on the sheet 18, such as at the distal end 30 of the sheet, at the proximal end 32 of the sheet, or under a sleeve cuff 122.

In another illustrative embodiment, a radiopaque material can be incorporated into any of the extracellular matrix-derived tissues, the submucosal tissue preparations, or the synthetic materials described above used to make the sheet 18. A radiopaque material can also be incorporated into any of the tethers 35, 37, 39, 128 described above. Incorporation of a radiopaque material makes the sheet 18 and/or tether 35, 37, 39, 128 visible under a fluoroscope, for example. In such an embodiment, the placement of the sheet 18 and or the tether 35, 37, 39, 128 can be confirmed by the physician. The puncture site location can also be determined in the event that the patient undergoes another surgical procedure at a later time.

In various illustrative embodiments, the radiopaque material can be a barium salt such as barium sulfate, barium fluoride, or barium polyacrylate, bismuth oxychloride, bismuth trioxide, titanium dioxide, zirconium oxide, zirconium dioxide, chromium oxide, zinc oxide, or other metal oxides, bismuth glass, or mixtures of any of these radiopaque materials, or any other radiopaque materials known in the art. The radiopaque material(s) can be incorporated into the extracellular matrix-derived tissues, the submucosal tissue preparations, or the synthetic materials by procedures known to those skilled in the art such as dipping, coating, laminating, or encapsulating. In another illustrative embodiment, radiopaque marks, such as stripes and/or dots, can be placed strategically to locate the distal end 30 of the sheet, the proximal end 32 of the sheet 18, or a sleeve cuff 122, for example.

In another illustrative embodiment, radiopaque marks (e.g., bands, dots, dashes, and the like) can be used to mark the sheath 16 to aid the physician in visualizing sheath 16 and sheath 16 to sheet 18 placement. In another embodiment, or in addition to marking the sheath 16, radiopaque marks can be placed on the introducer 10 or on an access needle to determine the depth of the vessel and to indicate the proper placement of the sheet 18 at the vessel. In other embodiments, radiopaque marks can be used to mark any other component of the device described herein. Any of the radiopaque materials described herein or any other radiopaque materials known in the art can be used to mark one or more components of the device described herein.

In other illustrative aspects (see FIG. 12), mannitol or other pastes 134 known in the art, or a biocompatible liquid or solid lubricant 136 can be added to the distal end 30 of the sheet 18. Pastes 134 or biocompatible liquid or solid lubricants 136, for example, will provide a means of preventing the distal end 30 of the sheet 18 from rolling up upon insertion of the introducer with the sheet 18 into the patient by serving as a transition between the sheath 16 and the sheet 18 during insertion of the device into the patient (see FIG. 12). Mannitol and similar pastes 134, for example, will also be safely and rapidly dissolved during/after insertion of the introducer with the sheet 18 into the patient. The pastes 134 and biocompatible lubricants 136 should be capable of being sterilized by conventional techniques (e.g., autoclaving, filtering, irradiation) used for sterilizing pharmaceuticals and medical devices, and can be applied in the form of a liquid or gel, for example. Illustrative biocompatible lubricants 136 include hyaluronic acid, dextran sulfate, dextran, succinylated noncrosslinked collagen, methylated non-cross-linked collagen, glycogen, glycerol, dextrose, maltose, and triglycerides.

The present invention is also directed to a method of sealing a puncture site in the wall of a tubular tissue structure or the wall of a body cavity. The method comprises the step of inserting submucosal tissue or another intact extracellular matrix-derived tissue of a warm-blooded vertebrate or a synthetic bioabsorbable material into the puncture site. In accordance with the invention, “intact extracellular matrix-derived tissue” means an extracellular matrix-derived tissue at least a portion of which is in its native three-dimensional configuration. The tissue can be in the form of, for example, a ribbon, a cylindrically-shaped tube, a disk, or a roll and can be inserted into the puncture site in the form of a sheet 18 on any type of introducer element used to provide access to the lumen of a tubular tissue structure or to access a body cavity.

In one embodiment the method comprises the step of inserting an introducer element into the puncture site. An exemplary embodiment is depicted in FIG. 10 A and the introducer 10 has a sheet 18 comprising submucosal tissue or another extracellular matrix-derived tissue of a warm-blooded vertebrate or a synthetic bioabsorbable material and the sheet 18 has a user distal end 30 and a user proximal end 32. The user proximal end 32 of the sheet 18 remains outside of the punctured wall and the user distal end 30 of the sheet 18 is inserted into the tubular tissue structure 78. The sheet 18 has at least one tether 37 for positioning the user distal end 30 relative to the puncture site. The method further comprises the steps of pulling the tether 37 to position the user distal end 30 of the sheet 18 relative to the puncture site (see FIG. 10 C) and further pulling the tether 37 to position the user distal end 30 of the sheet 18 within the puncture site (see FIG. 10 D) to seal the puncture site upon removal of the introducer 10 from the tubular tissue structure 78 (see FIG. 10 E-F).

As shown in the embodiment of the invention depicted in FIG. 10, an introducer 10 with a sheet 18 is inserted through the skin, the underlying muscle tissue, and through the blood vessel wall (FIG. 10 A). As shown in FIG. 10 A, the user proximal end 32 of the sheet 18 remains outside of the blood vessel wall and the user distal end 30 of the sheet 18 enters the blood vessel when the introducer 10 is inserted into the blood vessel. In the embodiment of the invention shown in FIG. 10, a positioning tube 44 is positioned between the sheath 16 and the sheet 18 and the positioning tube 44 is used to insert the sheet 18 to a predetermined position relative to the sheet 18 by causing resistance when the tapered ledge 42 of the positioning tube 44 reaches the outside of the vessel wall (see FIG. 10 A). As discussed above, the submucosal tissue or another extracellular matrix-derived tissue or synthetic bioabsorbable material begins the remodeling process upon insertion of the introducer 10 and the sheet 18 through the blood vessel wall.

As is also shown in FIG. 10 A, pull-up 37 and pull-down 39 tethers are attached at or near to the user distal end 30 and user proximal end 32 of the sheet 18, respectively, and are exposed externally. FIG. 10 B depicts the cutting of the retaining tether 35 (e.g., a retaining tether 35 attached to the introducer 10, for example, to the sheath cap 20 or to the valve cap 22), so that the sheet 18 can be pulled up the introducer 10 using the pull-up tether 37. FIG. 10 C shows how the puncture site is sealed by pulling the user proximal end 43 of the pull-up tether 37 to gather the sheet 18 in the puncture site in the blood vessel wall. The sheet 18 may be gathered along the guide wire as the guide wire is removed from the lumen of the blood vessel. As shown in FIG. 10 D, the user proximal end 43 of the pull-up tether 37 is then pulled further to position the sheet 18 in the puncture site to form a hemostatic seal. As shown in FIG. 10 D-E, the unattached end 47 of the pull-down tether 39 is also pulled to gather the sheet 18 at the puncture site outside the vessel wall. As shown in FIG. 10 E, as the introducer 10 is pulled out of the puncture site, the externally exposed end of the sheet 18 can be tucked under the skin, and can be further tucked under the skin as shown in FIG. 10 F. As depicted in FIG. 10 G, the sheet 18 forms a plug in the puncture site and remodels the connective tissue to form a hemostatic seal. The exposed portion of the tethers can be removed by cutting. In the above-described method, the sheet 18 can be gathered into the puncture site after, during, or before removal of any of the components of the introducer element.

In another illustrative embodiment, the sheet 18 can be gathered in an extravascular location. In one illustrative embodiment, the sheet 18 is gathered as described in FIG. 10. In another illustrative embodiment, the pull-up tether and the pull-down tether can constitute a single tether 150 as described in detail above. In this embodiment, the tether can be fixed to the proximal end 32 of the sheet 18 and can be stitched axially down the sheet 18 to the distal end 30 of the sheet 18. The tether can then be stitched axially up the sheet 18 to the proximal end 32 of the sheet 18 and is externally exposed so that the user can grasp the tether.

In either of these illustrative embodiments the sheet 18 can be gathered in an extravascular location. When the sheet 18 is gathered in an extravascular location, a stepped dilator can be used to predilate the puncture site prior to inserting the sheath 16 and the sheet 18 into the puncture site. The transition between the two steps in the stepped dilator permits the distal portion of the stepped dilator to enter the vessel, but the proximal portion of the stepped dilator is prevented from entering the vessel. As a result, the sheet 18, on the proximal portion of the stepped dilator, cannot enter the vessel. Accordingly, when the user pulls the tether, the sheet 18 gathers outside of the vessel wall in an extravascular location. This illustrative embodiment can be used in combination with any embodiment of a retaining tether 35 and/or with any embodiment of a safety tether 128. In one illustrative aspect, this tether embodiment can include a knotting mechanism, such as a fisherman's knot, to keep the gathering from being reversed.

In another illustrative embodiment, where the sheet 18 is gathered in an extravascular location, a stepped dilator can be used to predilate the puncture site prior to inserting the sheath 16 and the sheet 18 into the puncture site. The transition between the two steps in the stepped dilator permits the distal portion of the stepped dilator to enter the vessel, but the proximal portion of the stepped dilator is restricted from entering the vessel. As a result, the sheet 18 on the proximal portion of the stepped dilator is restricted from entering the vessel. A pusher device can be used to compress the sheet 18 and gather the sheet 18 outside of the vessel wall in the extravascular location. Manual pressure or the pusher device can then be used to stabilize the sheet 18 outside of the vessel wall in the extravascular location during removal of the sheath 16.

As shown in FIG. 13, in another illustrative embodiment where the sheet 18 is placed in an extravascular location, the sheath 16 can be inserted until the sheet 18 contacts the outside of the vessel (FIG. 13) where resistance is encountered. In another illustrative aspect, a tactile stop can be used. The sheet 18 can then be released from the sheath 16 by removing the retaining wire 94 (FIG. 13). The sheet 18 can then be held in place in the extravascular location during sheath 16 removal by using manual pressure on the patient's skin above the sheet 18. The sheet 18 can remain in the extravascular location and to promote hemostasis. In another illustrative aspect, a stepped dilator, as described above, can be used in this embodiment.

In illustrative aspects of the method shown in FIG. 10, and all other methods described herein that involve gathering of the sheet 18, the stitch patterns 138, 140, 142, and 144 illustrated in FIG. 14 A-D for stitching the pull-up or the pull-down tether to the sheet 18 can be used. The stitch patterns 138, 140, 142, and 144 illustrated in FIG. 14 A-D can also be used in the illustrative embodiment described above where the pull-up and the pull-down tether constitute a single tether. In these illustrative embodiments the stitch patterns 138, 140, 142, and 144 comprise stitches of alternating longer and shorter lengths. In one illustrative embodiment, the tether is anchored to the sheet 18 by a knot 146 at the distal end 30 of the sheet 18. The stitch patterns 138, 140, 142, and 144 illustrated in FIG. 14 A-D result in a wide plug 148 as shown in FIG. 15 which may be less likely to pull out of the puncture site in the vessel during gathering of the sheet 18, and during removal of components of the introducer element from the puncture site. The wide plug 148 may also enhance hemostasis.

In another embodiment, the method comprises the step of inserting a bioabsorbable material (e.g., an extracellular matrix-derived tissue, submucosal tissue, or a synthetic bioabsorbable material) with a separate attached tether into a puncture site so that the bioabsorbable material includes an extravascular portion and an intravascular portion and an intermediate portion that extends through the puncture site to seal the puncture site. An illustrative embodiment of the method is depicted in FIGS. 11 A-F.

As shown in the illustrative embodiment depicted in FIGS. 11 A-F, an introducer 10 with a sheet 18 of a bioabsorbable material is inserted through the skin, the underlying muscle tissue, and through the blood vessel wall (FIG. 11 A). As shown in FIG. 11 A, the user proximal end 32 of the sheet 18 remains outside of the blood vessel wall and the user distal end 30 of the sheet 18 enters the blood vessel when the introducer 10 is inserted into the blood vessel. In the embodiment of the invention depicted in FIG. 11, a sleeve cuff 122 is attached to the sheet 18 to act as a tactile stop and the sleeve cuff 122 is used to insert the sheet 18 to a predetermined position in the muscle tissue by causing resistance when the edges 126 of the sleeve cuff 122 reach the outside of the vessel wall (see FIG. 11 A). The bioabsorbable material (e.g., submucosal tissue or another extracellular matrix-derived tissue or a synthetic bioabsorbable material) begins remodeling the puncture site upon insertion of the introducer 10 and the sheet 18 through the blood vessel wall.

As is also shown in FIG. 11 A, a safety tether 128 can be stitched to the sheet 18 axially down the length of the sheet 18 and axially back up the length of the sheet 18 leaving an unstitched portion to make the tether 90 in the form of a loop. The first end 130 and the second end 132 of the safety tether 128 can extend outside of the patient's skin as a safety feature so that the first end 130 and the second end 132 of the safety tether 128 can be pulled to remove the sheet 18 from the puncture site, if necessary, after the introducer 10 has been removed.

In the embodiment depicted in FIG. 11, a retaining wire 94 mechanism is used to prevent the sheet 18 from rolling up the introducer 10 when the introducer is inserted into the patient. In the embodiment depicted in FIG. 11, the retaining wire 94 extends through the lumen 124 between the dilator 17 and the sheath 16. As shown in FIG. 11 B, after the introducer 10 with the sheet 18 of bioabsorbable material is inserted through the vessel wall, the retaining wire 94 can be removed so that the tether 90 is no longer anchored by the retaining wire 94 and so that the sheet 18 is released from the introducer 10. The introducer 10 can then be removed as shown in FIGS. 11 C and D.

As shown in FIGS. 11 C and D, the introducer 10 can be pulled out of the puncture site, and the sheet 18 with the attached safety tether 128 is left in the puncture site. The externally exposed ends 130, 132 of the safety tether 128 can be cut (see FIG. 11 E). As depicted in FIG. 11 F, the distal end 30 of the sheet 18 then folds against the blood vessel wall due to blood flow and absorbs to the inside of the vessel wall. A hemostatic seal is formed in the puncture site due to absorption of the distal end 30 of the sheet 18 into the vessel wall and due to remodeling of the puncture site tissue by the sheet 18 material.

As is illustrated in FIGS. 10 A-F, FIGS. 11 A-F, and FIG. 13 in the illustrated embodiments of the invention, puncture sites are sealed in walls of blood vessels in patients undergoing catheterization. Although the use of an introducer 10 adapted for catheterization is illustrated in FIGS. 10, 11, and 13 it is understood that the present invention is applicable to any type of procedure in which an introducer element is used to provide access to the lumen of a tubular tissue structure, such as a blood vessel, or to a body cavity. For example, the present invention is applicable to procedures in which an introducer element such as a needle, a cannula, a guide wire, an introducer element adapted for dialysis, a trocar, or any other introducer element used to access the lumen of a tubular tissue structure or to a body cavity is used.

While the sealing device has been described as sheet 18, other physical forms are envisioned. More specifically, embodiments using collagen, gelatin, and other suitable materials may be used in a liquid, gel, or other solid form. In liquid and gel embodiments, as shown in FIG. 16, a ring 500 is provided around the exterior of sheath 16, or, when used, on positioning tube 44. Ring 500 includes a substantially hollow inner cavity 502 that is fluidly coupled to a fluid passageway 504 at a distal end of the passageway 504. Fluid passageway 504 is also fluidly coupled at a proximal end to a bulb 506 or other source of selectively applied pressure such as a syringe. The ring 500, passageway 504 and bulb 506 may be integral with positioning tube 44 or may be a separate piece that slides over and along tube 44. The ring 500 provides a tactile stop to indicate when the ring 500 abuts the tubular tissue structure 78. The sealing material is pre-loaded into cavity 502 and possibly a portion of passageway 504 and bulb 506 before introducer 10 is inserted into a patient. The ring 500 includes one or more voids in the outer wall 508 thereof. Upon pressure being applied to bulb 506, the sealing material is urged out of the voids in wall 508. This release of the sealing material effectively uncouples the sealing material from the sheath 16 and allows it to be deposited at the puncture site. Once out of cavity 502, the sealing material fills in the space vacated by removing the introducer 10 and seals the access point.

Alternative embodiments provide ring 500 as a gelatin, carbohydrate gum from vegetable cellulose, or other decomposable material walled ring, shown in FIGS. 18a-b. Such embodiments provide the liquid, gel, or initially solid sealing member (a hemostatic agent not shown) within cavity 502a and do not necessarily have a passageway 504. The ring 500a again provides a tactile stop to indicate when the ring 500a abuts the tubular tissue structure 78. In certain embodiments, the ring 500a floats upon the sheath 16 such that the ring 500a remains at the outside of the tubular tissue structure 78 as differing insertion depths of the sheath 16 are used. Upon making contact with tissue, the gelatin walls of ring 500a begin to decompose. The particular decomposition time and profile can be engineered by altering the composition of the gelatin used in the gelatin wall. Embodiments are envisioned where a user may select a specific gelatin walled capsule 500a (or any other of the bioabsorbable hemostasis offerings) having characteristics that best meet the needs of the particular procedure to be performed. For example, a user may have a multitude of gelatin capsules 500a with release times between thirty seconds (or shorter) and up to an hour (or longer) from which to choose. Once chosen, the user may slide the capsule 500a onto the sheath 16 before inserting the device 10 into a patient. Upon sufficient decomposition of the gelatin wall, the sealing member is released such that removal of the sheath 16 allows the sealing member to remain at the access site and to seal the access site. The chosen decomposition time for the gelatin wall is typically less than the time to complete the medical procedure such that the sealing member is deployed by the time the user is ready to remove sheath 16. The decomposed gelatin wall itself may be constructed from a hemostatic agent, to thereby assist in the sealing of the access site once dissolved. Similarly, the capsule 500a may be initially solid throughout and constructed from the chosen hemostatic agent.

In addition to the tethering of the sheet 18 to the positioning tube 44 or directly to sheath 16, other means of attachment are envisioned. Such attachment methods include: providing a snap fit or resistance fit, chemically bonding or gluing, and providing a common dilator cover 550. When attaching the sheet 18, or other sealing member, to sheath 16, or the positioning tube, the attachment is provided to allow proper placement of the sheet 18 by moving the sheath 16 or the positioning tube 44, and to then allow the sheath 16 or the positioning tube 44 to disengage from the sheet 18 to leave the sheet 18 at the access site when desired. Accordingly, any attachment that achieves these goals is suitable. Embodiments utilizing a snap fit or resistance fit provide for disengagement of the sheet 18 when a resistance is encountered that overcomes the snap/resistance attachment of the sheet 18. The resistance provided by the tubular tissue structure 78 is greater than the resistance provided by general tissue. Accordingly, the holding force of the snap fit/resistance fit is engineered to be greater than the resistance of general tissue, but less than the resistance provided by the tubular tissue structure 78. When the sheet 18, or cuff 122, encounters the tubular tissue structure 78 and the sheath 16 or the positioning tube 44 is further urged into the tubular tissue structure 78, the snap fit/resistance is overcome to un-bind the sheet 18 from the sheath 16 or the positioning tube 44. Un-binding the sheet 18 upon sheet 18 or cuff 122 and tubular tissue structure 78 abutment places the sheet 18 either across the structure wall 18 (like shown in FIGS. 10a-g) or outside the structure wall 18 (like shown in FIG. 13) respectively.

Embodiments using chemical bonding or gluing include chemicals or glues that either dissolve or disengage during the procedure. Such dissolution or disengagement may be a reaction, delayed or immediate, to exposure to solvents within the body, a reaction to air, a reaction to an introduced reagent, or a reaction to an other reagent. Also, the chemical bonding or gluing may be overcome by resistance provided by sheet 18 or cuff 122 encountering the tubular tissue structure 78.

FIGS. 17A-D show the embodiment where a common dilator cover 550 is provided for the sheath 16 and sheet 18. Dilator cover 550 includes a balloon sheath 552 that is coupled to dilator 17 at a distal end and is positioned between dilator 17 and sheath 16 when assembled. Balloon sheath 552 is formed from a sheer flexible material, such as Nylon, polyester, PVA biaxially oriented film sold under the trade name of Bovlon, and others. FIG. 17A shows the distal end of assembled introducer 10 before insertion into a body. Balloon sheath 552 extends out of the distal end of sheath 16 and then back towards the proximal end of the introducer 10 so as to cover the distal end of sheet 18. Once the distal end of the sheet 18 is covered, the balloon sheath 552 doubles back over itself and extends distally past the end of the sheath 16, and couples to the dilator 17. Accordingly, when presented to the body and to the tubular wall structure 78, the shoulders created by the ends of the sheath 16 and the sheet 18 are covered by the balloon sheath 552. The balloon sheath 552 thereby encourages balloon sheath 552 to glide along tissue and to not catch on the shoulders created by the ends of the sheath 16 and the sheet 18. Once the sheet 18 is properly placed via the tactile stop provided by cuff 122, the user may remove the dilator 17 and the balloon sheath 522. The dilator 17 and the balloon sheath 522 are removed by first extending the dilator 17 further distally relative to the sheath 16, the sheet 18, and the majority of the balloon sheath 522. The distal end of the balloon sheath 522 is coupled to the dilator 17 near the distal end of the dilator 17. Accordingly, the movement of the dilator 17 pulls the balloon sheath 522 therewith and disengages the covering relationship that the balloon sheath 522 has with the sheet 18 and sheath 16 as shown in FIG. 17C. Next, the user pulls on the head 544 of the dilator cover 550 to pull it and the attached dilator 17 out of the sheath 16 to open up the lumen of the sheath 16 for desired implements to travel therein. FIG. 17D shows the dilator 17 and the balloon sheath 522 partially retracted. Embodiments having the dilator cover 550 do not need the retaining wire 94 in that the balloon sheath 550 lessens the forces seen by the distal end of the sheet 18 that would potentially cause the sheet 18 to move on the sheath 16. Accordingly, embodiments having only the pull up tether 37, as well as other embodiments, are suitable for use with dilator cover 550. Removal of the dilator and balloon sheath 522 provides more space within the lumen of the sheath 16 for instruments desiring access to the tissue.

While certain embodiments of the present invention have been described in detail, those familiar with the art to which this invention relates will recognize various alternative designs and embodiments for practicing the invention as defined by the following claims.

	Number	Date	Country
Parent	11180379	Jul 2005	US
Child	11546079	Oct 2006	US

Information

Publication Number

Date Filed

Date Published

Inventors

CPC

US Classifications

International Classifications

Abstract

Description

Claims

CROSS-REFERENCE TO RELATED APPLICATIONS

Continuation in Parts (1)